Gewählte Publikation:
SHR
Neuro
Krebs
Kardio
Lipid
Stoffw
Microb
Stadler, M; Zlamal-Fortunat, S; Schütz-Fuhrmann, I; Rami-Merhar, B; Fröhlich-Reiterer, E; Hofer, S; Mader, J; Resl, M; Kautzky-Willer, A; Weitgasser, R; Prager, R; Bischof, M.
[Insulin pump therapy in children, adolescents and adults].
Wien Klin Wochenschr. 2016; 128 Suppl 2(4):S188-S195
Doi: 10.1007/s00508-016-0966-0
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
-
Fröhlich-Reiterer Elke
-
Mader Julia
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
-
This position statement is based on the current evidence available on the safety and benefits of continuous subcutaneous insulin pump therapy (CSII) in diabetes with an emphasis on the effects of CSII on glycemic control, hypoglycaemia rates, occurrence of ketoacidosis, quality of life and the use of insulin pump therapy in pregnancy. The current article represents the recommendations of the Austrian Diabetes Association for the clinical praxis of insulin pump treatment in children, adolescents and adults.
- Find related publications in this database (using NLM MeSH Indexing)
-
Adolescent -
-
Adult -
-
Austria -
-
Child -
-
Child, Preschool -
-
Diabetes Mellitus - diagnosis
-
Diabetes Mellitus - drug therapy
-
Diabetes Mellitus - psychology
-
Dose-Response Relationship, Drug -
-
Drug Administration Schedule -
-
Drug Monitoring - psychology
-
Drug Monitoring - standards
-
Evidence-Based Medicine -
-
Female -
-
Humans -
-
Hypoglycemic Agents - administration & dosage
-
Insulin - administration & dosage
-
Insulin Infusion Systems - psychology
-
Insulin Infusion Systems - standards
-
Male -
-
Practice Guidelines as Topic -
-
Quality of Life - psychology
-
Treatment Outcome -
-
Young Adult -
- Find related publications in this database (Keywords)
-
Insulin pump therapy
-
Guidelines
-
Diabetes mellitus